Professor of Thoracic and Cardiac Surgery, University Louisville School of Medicine
Thoracic Surgery
Dr. Mark Slaughter, MD
|
|
Give Review
Mark Slaughter is an expert in the field of Thoracic Surgery. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He received awards:"Ethics Committee", "Associate Editor", "Editor in Chief" and "Fellow (FACS)". Mark Slaughter is a published doctor. He has 99 publications published. The most current publication "Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor."
Publications
- Left ventricular assist devices: current controversies and future directions.
- Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor.
- The current state of left ventricular assist devices: challenges facing further development.
- Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
- Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
- Gastrointestinal Bleeding in Recipients of the HeartWare Ventricular Assist System.
- Left Ventricular Volume Unloading with Axial and Centrifugal Rotary Blood Pumps.
- Hemodynamic Changes and Retrograde Flow in LVAD Failure.
- Rotary pump speed modulation for generating pulsatile flow and phasic left ventricular volume unloading in a bovine model of chronic ischemic heart failure.
- An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) ...
- Comparison of continuous-flow and pulsatile-flow left ventricular assist devices: is there an advantage to pulsatility?
- Suction prevention and physiologic control of continuous flow left ventricular assist devices using intrinsic pump parameters.
- Feasibility study of particulate extracellular matrix (P-ECM) and left ventricular assist device (HVAD) therapy in chronic ischemic heart failure bovine model.
- Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failure.
- Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.
- Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant.
- Early Feasibility Testing and Engineering Development of a Sutureless Beating Heart (SBH) Connector for Left Ventricular Assist Devices (LVAD).
- Development of an Extracellular Matrix (ECM) Delivery System for Effective Intramyocardial Injection in Ischemic Tissue.
- Extended Extra-aortic Counterpulsation With the C-Pulse Device Does Not Alter Aortic Wall Structure.
- Bud Frazier's 1,000th Implantation of a Ventricular Assist Device.
- The Association of Pre-transplant HeartMate® II Left Ventricular Assist Device Placement and Heart Transplantation Mortality.
- Early Feasibility Testing and Engineering Development of the Transapical Approach for the HeartWare MVAD Ventricular Assist System.
- Large Animal Models for Left Ventricular Assist Device Research and Development.
- Long-term mechanical circulatory support for advanced heart failure: 'the tide is turning'.
- Preoperative Hematocrit Is a Powerful Predictor of Adverse Outcomes in Coronary Artery Bypass Graft Surgery: A Report From The Society of Thoracic Surgeons Adult Cardi...
- Early and Midterm Outcomes Following Surgery for Acute Type A Aortic Dissection.
- HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial.
- Percutaneous Closure of a Patent Foramen Ovale to Prevent Paradoxical Thromboembolism in a Patient With a Continuous-Flow LVAD.
- Mechanistic Pathway(s) of Acquired Von Willebrand Syndrome with a Continuous-Flow Ventricular Assist Device: In Vitro Findings.
- Management of Recurrent Leaks Following Postinfarction Ventricular Septal Defect Repairs.
- Summary of the 19th congress of the international society for rotary blood pumps.
- Control strategies for afterload reduction with an artificial vasculature device.
- Open repair of blunt thoracic aortic injury remains relevant in the endovascular era.
- Prospective clinical study of a novel left atrial appendage occlusion device.
- Editorial Commentary: Determining the cost-effectiveness of mechanical circulatory support.
- Antegrade versus Retrograde Cerebral Protection in Repair of Acute Ascending Aortic Dissection.
- Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
- Coronary Artery Fistula: 64-Slice Computed Tomographic Delineation and Correlation with Multiplane Transesophageal Echocardiography and Surgical Findings.
- Cost-Effectiveness Analysis of Continuous Flow Left Ventricular Assist Devices as Destination Therapy.
- Arterial conduits for surgical revascularization: the answer is ...
- Temporal Changes in Hospital Costs for Left Ventricular Assist Device Implantation.
- Welcome to the 19th congress of the international society for rotary blood pumps.
- Blood trauma testing for mechanical circulatory support devices.
- Continuous Aortic Regurgitation with Ventricular Assist Device.
- Destination therapy with left ventricular assist devices: patient selection and outcomes.
- Is female sex an independent risk factor for perioperative transfusion in coronary artery bypass graft surgery?
- Evaluation of new Forcefield technology: Reducing platelet adhesion and cell coverage of pyrolytic carbon surfaces.
- Transapical miniaturized ventricular assist device: Design and initial testing.
- Implantation of the HeartWare Left Ventricular Assist Device.
- UNOS Status of Heart Transplant Patients Supported with a Left Ventricular Assist Device: Is It Time to Reconsider the Status Criteria?
- Hematologic effects of continuous flow left ventricular assist devices.
- Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
- Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle.
- The ideal conduit for surgical revascularization: the quest for the holy grail continues.
- A novel subcutaneous counterpulsation device: acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failure.
- Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects.
- Introduction to LVAD Papers.
- Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
- Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults.
- Increase in circadian variation after continuous-flow ventricular assist device implantation.
- Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
- Destination therapy: one-year outcomes in patients with a body mass index greater than 30.
- Will destination therapy be limited to large transplant centers?
- Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
- Outcomes of Medicare beneficiaries with ventricular assist devices.
- Intraoperative evaluation of the HeartMate II flow estimator.
- HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test.
- Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
- Human, bovine and porcine systematic vascular input impedances are not equivalent: implications for device testing and xenotransplantation in heart failure.
- Reducing emboli in cardiac surgery: does it make a difference?
- Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function.
- Improvement in early oxygen uptake kinetics with left ventricular assist device support.
- Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome?
- Destination therapy: safety and feasibility of national and international travel.
- Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device.
- Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
- Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
- Utilization of acoustic signatures to identify HeartMate XVE device end-of-life.
- Home discharge experience with the Thoratec TLC-II portable driver.
- Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device.
- Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement.
- Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
- Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols.
- Embol-X intra-aortic filtration system: capturing particulate emboli in the cardiac surgery patient.
- Destination therapy: the future is arriving.
- Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.
- The Thoratec mobile computer: initial in-hospital and outpatient experience.
- Minimally invasive mitral valve repair using the da Vinci robotic system.
- Percutaneous endoscopic gastrostomy tube in a patient with a left ventricular assist device.
- In vivo evaluation of the biocompatibility of the totally implantable ventricular assist device (HeartSaver VAD).
- Rotary pumps and diminished pulsatility: do we need a pulse?
- Novel thrombosis risk index as predictor of left ventricular assist device thrombosis.
- Fault detection in rotary blood pumps using motor speed response.
- Benefits of aggressive medical management in a bovine model of chronic ischemic heart failure.
- Flow modulation algorithms for intra-aortic rotary blood pumps to minimize coronary steal.
- Do Axial-Flow LVADs Unload Better than Centrifugal-Flow LVADs?
- Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device.
- Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
Schools
Indiana University School Of Medicine
Northwestern Memorial Hospital
University Of Minnesota Medical SchoolTwin Cities
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Aortic Repair, Open or Repair of Arterial Aneurysm, Open
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Doctors Specialties
- Cardiothoracic Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- Ethics Committee
- Associate Editor
- Editor in Chief
- Fellow (FACS)
Education
-
University of Minnesota -
McGaw Medical Center of Northwestern University -
Indiana University School of Medicine
Hospital
-
Jewish Hospital -
Norton Hospital -
University of Louisville Hospital -
Kosair Children's Hospital
Drug Facts
| NPI NUMBER | 1326034760 | |
| NPPES Provider LastName | SLAUGHTER | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 402023841 | |
| NPPES Provider State | KY | |
| Specialty Description | Cardiac Surgery | |
| Total Claim Count | 100.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 13.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326034760 |
| Last Name Of The Provider | SLAUGHTER |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Anna L. Meyer, MD |
|
|
Dr. Steven M. Peterson, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew L. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher E. Mascio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laman A. Gray Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Wrightson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Victor H. VanBerkel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence G. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John D. Rumisek, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kendra J. Grubb, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Allen Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brian L. Ganzel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sebastian Pagni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel J. Youssef, MD
This Doctor is OpenDoctor Recommended.
|